These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3858877

  • 1. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
    Langsjoen PH, Vadhanavikit S, Folkers K.
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4240-4. PubMed ID: 3858877
    [Abstract] [Full Text] [Related]

  • 2. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P.
    Klin Wochenschr; 1988 Jul 01; 66(13):583-90. PubMed ID: 3062263
    [Abstract] [Full Text] [Related]

  • 3. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
    Langsjoen PH, Vadhanavikit S, Folkers K.
    Drugs Exp Clin Res; 1985 Jul 01; 11(8):577-9. PubMed ID: 3836875
    [Abstract] [Full Text] [Related]

  • 4. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.
    Folkers K, Vadhanavikit S, Mortensen SA.
    Proc Natl Acad Sci U S A; 1985 Feb 01; 82(3):901-4. PubMed ID: 3856239
    [Abstract] [Full Text] [Related]

  • 5. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.
    Folkers K, Wolaniuk J, Simonsen R, Morishita M, Vadhanavikit S.
    Proc Natl Acad Sci U S A; 1985 Jul 01; 82(13):4513-6. PubMed ID: 3859873
    [Abstract] [Full Text] [Related]

  • 6. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
    Mortensen SA.
    Biofactors; 2003 Jul 01; 18(1-4):79-89. PubMed ID: 14695923
    [Abstract] [Full Text] [Related]

  • 7. Myocardial preservation by therapy with coenzyme Q10 during heart surgery.
    Judy WV, Stogsdill WW, Folkers K.
    Clin Investig; 1993 Jul 01; 71(8 Suppl):S155-61. PubMed ID: 8241702
    [Abstract] [Full Text] [Related]

  • 8. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K, Langsjoen P, Langsjoen PH.
    Biochem Biophys Res Commun; 1992 Jan 15; 182(1):247-53. PubMed ID: 1731784
    [Abstract] [Full Text] [Related]

  • 9. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP, Q-SYMBIO Study Investigators.
    JACC Heart Fail; 2014 Dec 15; 2(6):641-9. PubMed ID: 25282031
    [Abstract] [Full Text] [Related]

  • 10. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
    Folkers K, Wolaniuk A.
    Drugs Exp Clin Res; 1985 Dec 15; 11(8):539-45. PubMed ID: 3836873
    [Abstract] [Full Text] [Related]

  • 11. Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial.
    Donnino MW, Mortensen SJ, Andersen LW, Chase M, Berg KM, Balkema J, Radhakrishnan J, Gazmuri RJ, Liu X, Cocchi MN.
    Crit Care; 2015 Jul 01; 19(1):275. PubMed ID: 26130237
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
    Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, Manning P, Powers SW, Hershey AD.
    Cephalalgia; 2011 Jun 01; 31(8):897-905. PubMed ID: 21586650
    [Abstract] [Full Text] [Related]

  • 13. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10.
    Langsjoen PH, Langsjoen PH, Folkers K.
    Int J Tissue React; 1990 Jun 01; 12(3):169-71. PubMed ID: 2276895
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
    Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.
    JAMA Neurol; 2014 May 01; 71(5):543-52. PubMed ID: 24664227
    [Abstract] [Full Text] [Related]

  • 15. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations.
    Taggart DP, Jenkins M, Hooper J, Hadjinikolas L, Kemp M, Hue D, Bennett G.
    Ann Thorac Surg; 1996 Mar 01; 61(3):829-33. PubMed ID: 8619701
    [Abstract] [Full Text] [Related]

  • 16. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
    Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne BA, Aravot D.
    Clin Cardiol; 2004 May 01; 27(5):295-9. PubMed ID: 15188947
    [Abstract] [Full Text] [Related]

  • 17. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P.
    Int J Tissue React; 1990 May 01; 12(3):163-8. PubMed ID: 2276894
    [Abstract] [Full Text] [Related]

  • 18. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U, Rossi E, Littarru GP, Frustaci A, Lippa S, Oradei A, Aureli V.
    Int J Tissue React; 1990 May 01; 12(3):173-8. PubMed ID: 2276896
    [Abstract] [Full Text] [Related]

  • 19. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.
    Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Aström H.
    J Card Fail; 1995 Mar 01; 1(2):101-7. PubMed ID: 9420639
    [Abstract] [Full Text] [Related]

  • 20. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F, Rezavandi Z, Dadkhah Tehrani S, Farrokhian A, Asemi Z.
    Eur J Nutr; 2016 Dec 01; 55(8):2357-2364. PubMed ID: 26385228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.